Online Media Kit

FEATURED STORY

January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »

FEATURED STORY

November 30, 2020 | New York Times

Berry-Flavored H.I.V. Medication Is Ready for Babies

The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »

FEATURED STORY

July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »

FEATURED STORY

July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

Media Highlights

July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »

July 29, 2020 | Radio VOP (Zimbabwe)

Dapivirine Ring-another HIV prevention tool for women

The prospects of women in Sub Saharan Africa accessing a long acting HIV prevention tool that gives them control over their sexual health, increased last Friday after an independent scientific agency... More »

July 29, 2020 | Medscape

EMA Backs Dapivirine Vaginal Ring for HIV Prevention Outside of EU

The CHMP of the EMA has adopted a positive opinion on the dapivirine vaginal ring for the reduction of risk for HIV infection women in low- and middle-income countries outside the European Union. More »

July 29, 2020 | Apotheke Adhoc (Germany)

Dapivirin: HIV-Prävention für Frauen

The vaginal ring releases the antiretroviral agent dapivirine over 30 days and thus offers a discreet and long-term HIV prevention method.  More »

July 28, 2020 | The Pink Sheet

Dapivirine HIV Ring: A Gamechanger For African Women

The EU’s backing for the ring is being seen as a welcome addition to efforts to tackle the spread of HIV in lower resourced countries, particularly in sub-Saharan Africa. More »

Pages